Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-29 @ 7:21 AM
Study NCT ID:
NCT00895934
Status:
COMPLETED
Last Update Posted:
2019-05-23
First Post:
2009-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-07
First Submit QC Date:
None
Study First Post Date:
2009-05-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-06
Results First Submit QC Date:
None
Results First Post Date:
2015-02-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-02
Last Update Post Date:
2019-05-23
Last Update Post Date Type:
ACTUAL